Seeking Alpha

Par Pharmaceutical (PRX +1.8%) is trading higher after acquiring rights to three generic...

Par Pharmaceutical (PRX +1.8%) is trading higher after acquiring rights to three generic products from Teva Pharmaceuticals (TEVA -0.5%): fentanyl citrate lozenges, cyclobenzaprine ER capsules and the generic version of Provigil.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)